期刊文献+

miR-218-1-3p对非小细胞肺癌细胞侵袭和迁移影响 被引量:4

Effects of miR-218-1-3p on cell migration and invasion in non-small cell lung cancer
原文传递
导出
摘要 目的非小细胞肺癌(non-small cell lung cancer,NSCLC)因其侵袭性而导致预后不良,miR-218可对多种肿瘤的进展起到抑制作用。本研究探讨miR-218-1-3p对NSCLC A549细胞侵袭和迁移影响。方法使用LipofectamineTM2000Reagent将miR-218-1-3p mimic转染入NSCLC A549细胞中,实时定量聚合酶链反应(real-time PCR,RT-qPCR)检测各组细胞中miR-218-1-3p的表达,Transwell小室法测定其侵袭及迁移能力,荧光定量PCR检测细胞迁移侵袭相关指标基质金属蛋白酶2(matrix metalloproteinase 2,MMP-2)、MMP-7、MMP-9、RhoA、RhoB和RhoC的变化。结果同对照组相比,上调mir-218-1-3p明显抑制了A549细胞的侵袭(t=4.028,P=0.016)和迁移(t=8.911,P=0.001),其侵袭和迁移的抑制率分别为37.8%和53.6%。MMP-7降低至对照组的(0.68±0.19)倍,t=2.931,P=0.043;MMP-9降低至对照组的(0.58±0.15)倍,t=4.875,P=0.080。结论 miR-218-1-3p能够抑制NSCLC A549细胞的侵袭和迁移。 OBJECTIVE Non small-cell lung cancer leads to unfavourable prognosis because of invasion, miR-218 can inhibit the progression of multiple tumors. This research was to investigate the effect of miR-218-1-3p on the invasion and migration of A549 cells in non small cell lung cancer. METHODS miR-218-1-3p was transfected into non small cell lung cancer A549 cells by LipofectamineTM 2000 Reagent, the expression of miR-218-3p was detected by real time PCR. The invasion and migration were assayed by Transwell method. The changes of indicators related to cell migration and in vasion, MMP-2, MMP-7, MMP-9, Rho, A, Rho B, Rho C were detected by fluorescence quantitative PCR. RESULTS Comparing with control group,the cell invasion (t=4. 028,P=0. 016) and migration (t=8. 911,P=0. 001) of A549 were significantly inhibited by up-regulating mir-218-1 3p (P〈0.05), rating 37.8%and 53. 6%. MMP-7 de creased to (0.68±0.19) times of control group (t=2. 931,P=0. 043) and MMP 9 decreased to (0.58±0.15) times of control group (t=4. 875 ,P=0. 080). CONCLUSION miR-218-3p can inhibit the invasion and migration of non small cell lung cancer A549 cells.
作者 栾岚 张天戈 韩斌 初瑞 廖鑫 罗文婷 王翠芳 LUAN Lan ZHANG Tian-ge HAN Bin CHU Rui LIAO Xin LUO Wen-ting WANG Cui-fang(Department of Pathology,Central Hospital Affiliated to Shenyang Medical College, Shenyang 110024,P.R. China First Urology Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, P. R. China)
出处 《中华肿瘤防治杂志》 CAS 北大核心 2017年第14期955-959,共5页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(81401907) 沈阳医学院青年基金(20102029)
关键词 mir-218-1-3p 非小细胞肺癌 侵袭 迁移 mir-218-1-3 p non-small cell lung cancer invasion migration
  • 相关文献

参考文献2

二级参考文献16

  • 1Yanaihara N,Caplen N,Bowman E. Unique microrna molecular profiles in lung cancer diagnosis and prognosis[J].{H}CANCER CELLS,2006,(3):189-198.
  • 2Johnson SM,Grosshans H,Shingara J. RAS is regulated by the let-7 microrna family[J].{H}CELL,2005,(5):635-647.
  • 3Yang L,Li Q,Wang Q. Silencing of MiRNA-218 promotes migration and invasion of breast cancer via slit2-robol pathway[J].{H}Biomedicine and Pharmacotherapy,2012,(7):535-540.
  • 4Wu DW,Cheng YW,Wang J. Paxillin predicts survival and relapse in non-small cell lung cancer by microrna-218 targeting[J].{H}CANCER RESEARCH,2010,(24):10392-10401.
  • 5Tie J,Pan Y,Zhao L. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the robol receptor[J].{H}PLoS Genetics,2010,(3):e1000879.
  • 6Skalsky RL,Cullen BR. Reduced expression of brain-enriched micrornas in glioblastomas permits targeted regulation of a cell death gene[J].PloS One,2011,(9):e24248.
  • 7Ali S,Ahmad A,Aboukameel A. Increased ras gtpase activity is regulated by mirnas that can be attenuated by cdf treatment in pancreatic cancer cell[J].{H}CANCER LETTERS,2012,(2):173-181.
  • 8Takamizawa J,Konishi H,Yanagisawa K. Reduced expression of the let-7 micrornas in human lung cancers in association with shortened postoperative survival[J].{H}CANCER RESEARCH,2004,(11):3753-3756.
  • 9Ma L,Li GZ,Wu ZS. Prognostic significance of let-7b expression in breast cancer and correlation to its target gene of bsg expression[J].{H}MEDICAL ONCOLOGY,2014,(1):773.
  • 10Lebanony D,Benjamin H,Gilad S. Diagnostic assay based on hsa-mir-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma[J].{H}Journal of Clinical Oncology,2009,(12):2030-2037.

共引文献16

同被引文献38

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部